MENU
ABBV
AS OF
Nov 14, 11:53 AM (EDT)
Price
$232.21
Change
-$0.08 (-0.03%)
Capitalization
410.55B
82 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ABBV
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ABBVIE (ABBV) Earnings Date & Reports

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta)... Show more

A.I. Advisor
published Earnings

ABBV is expected to report earnings to rise 80.65% to $3.36 per share on February 04

ABBVIE ABBV Stock Earnings Reports
Q4'25
Est.
$3.36
Q3'25
Beat
by $0.08
Q2'25
Beat
by $0.01
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.10
The last earnings report on October 31 showed earnings per share of $1.86, beating the estimate of $1.78. With 530.44K shares outstanding, the current market capitalization sits at 410.55B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)
Annualized Return+8%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
ABBV
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABBV showed earnings on October 31, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ABBV
A.I. Advisor
published General Information

General Information

a research-based pharmaceutical company

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1 North Waukegan Road
Phone
+1 847 932-7900
Employees
50000
Web
http://www.abbvieinvestor.com